Recent progress in vaccine development targeting pre-clinical human toxoplasmosis
Ki-Back Chu, Fu-Shi Quan
Parasites Hosts Dis. 2023;61(3):231-239. Published online 2023 Aug 21 DOI: https://doi.org/10.3347/PHD.22097
Citations to this article as recorded by 
PLGA nanoparticles as an efficient carrier in Toxoplasma GAP45: a more effective vaccine against acute toxoplasmosis than traditional ones
Pan Zhou, YanLi Yu, WeiYu Qi, XiaoJuan Wang, YouLi Yu, JianDong Wang, Li Zhang, ZhengQing Yu, TingLi Liu
Frontiers in Immunology.2025;[Epub] CrossRef
Influenza virus-like particles presenting
Toxoplasma gondii
dense granule protein 7 protect mice from lethal ME49 challenge
Jie Mao, Hae-Ji Kang, Su-In Heo, Fu-Shi Quan
Nanomedicine.2025; 20(18): 2309. CrossRef
Recombinant TgDDX3X DEAD-box protein confers partial protection in murine models of acute and chronic toxoplasmosis
Shuai Wang, Jinghui Wang, Youke Fan, Haina Zhang, Junru Wu, Tingting Ying, Hangbin Ma, Qiangqiang Wang, Longkang Wang, Yuanfeng Wang, Xiaowei Tian, Xuefang Mei, Zhenchao Zhang, Zhenke Yang
Acta Tropica.2025; 270: 107780. CrossRef
Evaluation of protective efficacy of recombinant Toxoplasma gondii DDX39 protein vaccine against acute and chronic T. gondii infection in mice
Jinghui Wang, Yuanfeng Wang, Haina Zhang, Hangbin Ma, Qiangqiang Wang, Longkang Wang, Youke Fan, Xiaowei Tian, Xuefang Mei, Zhenchao Zhang, Shuai Wang, Zhenke Yang
Acta Tropica.2024; 260: 107442. CrossRef